https://consanobio.com/2025/11/19/consano-bio-presents-favorable-nonclinical-safety-results-for-c-1101-at-the-american-college-of-toxicology-46th-annual-meeting/ 2026-02-23T17:10:29+00:00 monthly 0.2 https://consanobio.com/2026/02/23/consano-bio-to-present-at-bio-investment-growth-summit-2026/ 2026-02-23T17:02:37+00:00 monthly 0.2 https://consanobio.com/2026/03/30/consano-bio-presents-preclinical-data-on-c-1101-at-ors-2026-annual-meeting/ 2026-03-30T19:17:35+00:00 monthly 0.2 https://consanobio.com/2026/05/26/consano-bio-initiates-phase-1-clinical-trial-of-c-1101-a-potential-first-in-class-non-opioid-therapy-for-chronic-sciatica/ 2026-05-27T16:42:16+00:00 monthly 0.2 https://consanobio.com/2026/06/10/consano-bio-to-present-clinical-development-of-c-1101-for-chronic-sciatica-at-2026-bio-international-convention/ 2026-06-10T19:35:07+00:00 monthly 0.2 https://consanobio.com/2026/06/29/consano-bio-highlights-scientific-advisory-board-for-c-1101-a-potential-first-in-class-non-opioid-therapy-in-development-for-chronic-sciatica/ 2026-06-29T12:08:23+00:00 monthly 0.2